VYNE Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYNE and other ETFs, options, and stocks.

About VYNE

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. 

CEO
David Domzalski
CEODavid Domzalski
Employees
13
Employees13
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2011
Founded2011
Employees
13
Employees13

VYNE Key Statistics

Market cap
15.83M
Market cap15.83M
Price-Earnings ratio
-0.96
Price-Earnings ratio-0.96
Dividend yield
—
Dividend yield—
Average volume
361.40K
Average volume361.40K
High today
$0.9903
High today$0.9903
Low today
$0.95
Low today$0.95
Open price
$0.965
Open price$0.965
Volume
91.69K
Volume91.69K
52 Week high
$4.30
52 Week high$4.30
52 Week low
$0.95
52 Week low$0.95

People also own

Based on the portfolios of people who own VYNE. This list is generated using Robinhood data, and it’s not a recommendation.
NIO
SNDL
Bionano Genomics
Castor Maritime
Workhorse
Plug Power
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.